Something significant is happening at the edges of cancer research — and it is not coming from pharmaceutical companies or oncology departments.

It is coming from a growing community of researchers, practitioners, and patients who have been asking a question that conventional oncology has largely refused to take seriously: what if some of the most effective anticancer compounds already exist — cheap, off-patent, widely available — and have been overlooked because there is no financial incentive to study them?

In March 2026, a declassified document circulated widely online and was covered by the Daily Mail — reportedly a historical CIA-linked document referencing research into potential cancer-fighting compounds including ivermectin. The story sparked furious public debate. It also opened a door that many in the integrative medicine community have been trying to open for years.